A combination of dipeptidyl peptidase-4 inhibitor and metformin in the treatment of patients with type 2 diabetes mellitus: effective control of glycemia, weight, and quantitative body composition

A combination of dipeptidyl peptidase-4 inhibitor and metformin in the treatment of patients with type 2 diabetes mellitus: effective control of glycemia, weight, and quantitative body composition

AIM: To study the impact of intensified therapy with the dipeptidyl peptidase-4 (DPP-4) inhibitor vilagliptin or sulfonylurea (SU) on the control of glycemia, weight, and quantitative body composition in patients with type 2 diabetes mellitus (DM-2) who have failed to achieve compensation during met...

Full description

Bibliographic Details
Main Authors: M V Shestakova, O Iu Sukhareva, T O Chernova, I A Shmushkovich, A A Aleksandrov, A V Il'in, I I Dedov
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2013-08-01
Series:Терапевтический архив
Subjects:
type 2 diabetes mellitus
quantitative body composition
adiponectin
vildagliptin
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31313

Internet

https://ter-arkhiv.ru/0040-3660/article/view/31313

Similar Items